BPLETE LIMITED

Active United Kingdom

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
B

BPLETE LIMITED

Research and experimental development on biotechnology

Founded 4 Jun 2021 Active United Kingdom 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

PROTEOMX LIMITED 4 Jun 2021 — 17 Nov 2023
Accounts Submitted 24 Apr 2026 Next due 31 May 2026 10 days overdue
Confirmation Submitted 3 Jun 2026 Next due 17 Jun 2027 12 months remaining
Net assets £-1M £691K 2025 year on year
Total assets £288K £746K 2025 year on year
Total Liabilities £1M £55K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Full company profile for BPLETE LIMITED (13439199), an active company based in United Kingdom. Incorporated 4 Jun 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Sept → 31 Aug 2025
Type small
Next accounts 31 Aug 2025
Due by 31 May 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2022–2025)

Cash in Bank

£233.24k

Decreased by £606.92k (-72%)

Net Assets

-£1.00M

Decreased by £691.49k (-222%)

Total Liabilities

£1.29M

Decreased by £54.99k (-4%)

Turnover

N/A

Employees

N/A

Debt Ratio

448%

Increased by 318 (+245%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Aug Year End
2024
31 Aug Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 3,875 Shares £3.875 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Dec 20253,875£3.875£0.001

Officers

Officers

3 active
Status
De Rubertis, FrancescoDirectorItalianSwitzerland569 Nov 2023Active
Grainger, David John, DrDirectorBritishEngland594 Jun 2021Active
The Cambridge Partnership LimitedCorporate-secretaryUnited KingdomUnknown28 Oct 2023Active

Shareholders

Shareholders (2)

Medicxi Iii Lp
98.3%
5,777
Medicxi Co-invest Iii Lp
1.7%
98

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased
Ceased

David John Grainger

Ceased 9 Nov 2023

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Jun 2026Confirmation StatementConfirmation statement made on 3 Jun 2026 with updates
24 Apr 2026AccountsAnnual accounts made up to 31 Aug 2025
13 Jan 2026CapitalAllotment of shares (GBP 5.88) on 18 Dec 2025
4 Jun 2025Confirmation StatementConfirmation statement made on 3 Jun 2025 with no updates
2 Jun 2025AccountsAnnual accounts made up to 31 Aug 2024
3 Jun 2026 Confirmation Statement

Confirmation statement made on 3 Jun 2026 with updates

24 Apr 2026 Accounts

Annual accounts made up to 31 Aug 2025

13 Jan 2026 Capital

Allotment of shares (GBP 5.88) on 18 Dec 2025

4 Jun 2025 Confirmation Statement

Confirmation statement made on 3 Jun 2025 with no updates

2 Jun 2025 Accounts

Annual accounts made up to 31 Aug 2024

Recent Activity

Latest Activity

Confirmation statement made on 3 Jun 2026 with updates

6 days ago on 3 Jun 2026

Annual accounts made up to 31 Aug 2025

1 months ago on 24 Apr 2026

Allotment of shares (GBP 5.88) on 18 Dec 2025

4 months ago on 13 Jan 2026

Confirmation statement made on 3 Jun 2025 with no updates

1 years ago on 4 Jun 2025

Annual accounts made up to 31 Aug 2024

1 years ago on 2 Jun 2025